Jiangsu Hengrui Medicine Co., Ltd. (SHA: 600276)
44.40
-0.60 (-1.33%)
Sep 6, 2024, 3:00 PM CST
Jiangsu Hengrui Medicine Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Cash & Equivalents | 22,312 | 20,746 | 15,111 | 13,631 | 10,805 | 5,044 | Upgrade
|
Trading Asset Securities | 973.23 | 99.05 | 2,760 | 5,090 | 5,628 | 8,520 | Upgrade
|
Cash & Short-Term Investments | 23,285 | 20,845 | 17,871 | 18,721 | 16,433 | 13,563 | Upgrade
|
Cash Growth | 37.30% | 16.64% | -4.54% | 13.93% | 21.15% | 248.70% | Upgrade
|
Accounts Receivable | 6,932 | 6,135 | 8,341 | 6,884 | 8,176 | 5,435 | Upgrade
|
Other Receivables | 390.46 | 438.25 | 562.18 | 658 | 651.15 | 982.05 | Upgrade
|
Receivables | 7,322 | 6,573 | 8,904 | 7,542 | 8,827 | 6,417 | Upgrade
|
Inventory | 2,252 | 2,314 | 2,451 | 2,403 | 1,778 | 1,607 | Upgrade
|
Prepaid Expenses | 237.12 | 226.07 | 507.2 | 431.57 | 410.18 | 86.07 | Upgrade
|
Other Current Assets | 1,680 | 1,329 | 1,201 | 1,090 | 602.25 | 638.13 | Upgrade
|
Total Current Assets | 34,777 | 31,287 | 30,934 | 30,188 | 28,050 | 22,311 | Upgrade
|
Property, Plant & Equipment | 6,634 | 6,629 | 6,676 | 6,276 | 4,585 | 4,075 | Upgrade
|
Long-Term Investments | 1,499 | 1,451 | 1,508 | 1,001 | 1,502 | 599.43 | Upgrade
|
Other Intangible Assets | 861.91 | 883.77 | 519.9 | 442.45 | 341.25 | 349.76 | Upgrade
|
Long-Term Deferred Tax Assets | 404.34 | 320.56 | 238.9 | 141.36 | 52.97 | 66.09 | Upgrade
|
Long-Term Deferred Charges | 3,613 | 2,829 | 2,052 | 569.38 | 197.63 | 155.09 | Upgrade
|
Other Long-Term Assets | 392.45 | 383.3 | 442.55 | 648.99 | - | - | Upgrade
|
Total Assets | 48,181 | 43,785 | 42,371 | 39,266 | 34,730 | 27,556 | Upgrade
|
Accounts Payable | 1,325 | 1,334 | 1,493 | 1,920 | 1,151 | 1,289 | Upgrade
|
Accrued Expenses | 122.33 | 139.95 | 97.57 | 165.66 | 130.54 | 185.29 | Upgrade
|
Short-Term Debt | - | - | 1,261 | - | - | - | Upgrade
|
Current Income Taxes Payable | 112.05 | 59.28 | 4.03 | 21.77 | 25.14 | 17.75 | Upgrade
|
Current Unearned Revenue | 1,226 | 198.09 | 187.08 | 219.55 | 358.06 | 222.64 | Upgrade
|
Other Current Liabilities | 1,987 | 822.32 | 596.13 | 1,074 | 2,107 | 757.7 | Upgrade
|
Total Current Liabilities | 4,808 | 2,554 | 3,639 | 3,402 | 3,772 | 2,473 | Upgrade
|
Long-Term Leases | 58.28 | 75.18 | 98.86 | 151.59 | - | - | Upgrade
|
Long-Term Unearned Revenue | 42.55 | 38.95 | 119.44 | 116.52 | 141.24 | 122.22 | Upgrade
|
Long-Term Deferred Tax Liabilities | 85.09 | 83.64 | 100.45 | 24.77 | 29.76 | 24.09 | Upgrade
|
Total Liabilities | 4,994 | 2,751 | 3,958 | 3,694 | 3,943 | 2,619 | Upgrade
|
Common Stock | 6,379 | 6,379 | 6,379 | 6,396 | 5,332 | 4,423 | Upgrade
|
Additional Paid-In Capital | 3,167 | 3,058 | 3,020 | 3,356 | 3,143 | 1,663 | Upgrade
|
Retained Earnings | 34,260 | 32,102 | 28,819 | 25,928 | 23,530 | 19,103 | Upgrade
|
Treasury Stock | -1,202 | -1,092 | -398.03 | -664.94 | -1,495 | -419.84 | Upgrade
|
Comprensive Income & Other | 18.55 | 19.32 | 3.23 | -12.16 | -4.79 | 6.53 | Upgrade
|
Total Common Equity | 42,622 | 40,466 | 37,824 | 35,003 | 30,504 | 24,775 | Upgrade
|
Minority Interest | 564.89 | 567.29 | 589.35 | 568.85 | 282.7 | 162.2 | Upgrade
|
Shareholders' Equity | 43,187 | 41,033 | 38,413 | 35,572 | 30,787 | 24,938 | Upgrade
|
Total Liabilities & Equity | 48,181 | 43,785 | 42,371 | 39,266 | 34,730 | 27,556 | Upgrade
|
Total Debt | 95.02 | 75.18 | 1,360 | 151.59 | - | - | Upgrade
|
Net Cash (Debt) | 23,190 | 20,770 | 16,511 | 18,570 | 16,433 | 13,563 | Upgrade
|
Net Cash Growth | 37.44% | 25.79% | -11.08% | 13.00% | 21.15% | 248.70% | Upgrade
|
Net Cash Per Share | 3.68 | 3.28 | 2.58 | 2.91 | 2.57 | 2.12 | Upgrade
|
Filing Date Shares Outstanding | 6,191 | 6,361 | 6,367 | 6,382 | 6,355 | 6,342 | Upgrade
|
Total Common Shares Outstanding | 6,191 | 6,361 | 6,367 | 6,382 | 6,355 | 6,342 | Upgrade
|
Working Capital | 29,968 | 28,734 | 27,295 | 26,786 | 24,278 | 19,839 | Upgrade
|
Book Value Per Share | 6.88 | 6.36 | 5.94 | 5.48 | 4.80 | 3.91 | Upgrade
|
Tangible Book Value | 41,760 | 39,582 | 37,304 | 34,561 | 30,163 | 24,426 | Upgrade
|
Tangible Book Value Per Share | 6.74 | 6.22 | 5.86 | 5.42 | 4.75 | 3.85 | Upgrade
|
Buildings | 3,899 | 3,854 | 3,541 | 2,700 | 2,141 | 1,720 | Upgrade
|
Machinery | 6,086 | 5,969 | 5,684 | 5,120 | 4,063 | 3,395 | Upgrade
|
Construction In Progress | 1,142 | 1,101 | 1,193 | 1,659 | 1,305 | 1,533 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.